NITROFURAZONE Drug Patent Profile
✉ Email this page to a colleague
When do Nitrofurazone patents expire, and when can generic versions of Nitrofurazone launch?
Nitrofurazone is a drug marketed by Ambix, Lannett, Perrigo New York, Taro, and Wendt. and is included in seven NDAs.
The generic ingredient in NITROFURAZONE is nitrofurazone. There are four drug master file entries for this compound. Additional details are available on the nitrofurazone profile page.
Summary for NITROFURAZONE
US Patents: | 0 |
Applicants: | 5 |
NDAs: | 7 |
Raw Ingredient (Bulk) Api Vendors: | 96 |
Clinical Trials: | 1 |
Patent Applications: | 2,803 |
Formulation / Manufacturing: | see details |
DailyMed Link: | NITROFURAZONE at DailyMed |
Recent Clinical Trials for NITROFURAZONE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Julio Ramirez | Early Phase 1 |
University of Louisville | Early Phase 1 |
James Graham Brown Cancer Center | Early Phase 1 |
Medical Subject Heading (MeSH) Categories for NITROFURAZONE
US Patents and Regulatory Information for NITROFURAZONE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ambix | NITROFURAZONE | nitrofurazone | OINTMENT;TOPICAL | 086077-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Wendt | NITROFURAZONE | nitrofurazone | SOLUTION;TOPICAL | 087081-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Taro | NITROFURAZONE | nitrofurazone | OINTMENT;TOPICAL | 086156-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lannett | NITROFURAZONE | nitrofurazone | OINTMENT;TOPICAL | 084393-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |